| Firm |
Analyst |
| Argus Research Company |
David A. Toung |
| Bank of America |
Travis Steed |
| Barclays |
Matthew Miksic |
| Baptista Research |
Ishan Majumdar |
| Bernstein |
Lee Hambright |
| BTIG |
Ryan Zimmerman |
| Canaccord Genuity |
Kyle Rose |
| Citi |
Joanne Wuensch |
| Cowen & Company, LLC |
Joshua T. Jennings |
| Deutsche Bank |
Pito Chickering |
| Evercore ISI |
Vijay Kumar |
| Jefferies, LLC |
Matthew Taylor |
| JMP Securities Inc. |
David Turkaly |
| J.P. Morgan |
Robert Marcus |
| KeyBanc Capital Markets |
Matthew Mishan |
| Morgan Stanley |
Andrew Ranieri |
| Needham & Company LLC. |
Michael Matson |
| Nephron Research |
Christopher Pasquale |
| Oppenheimer & Co. Inc. |
Steven M. Lichtman |
| Piper Sandler & Companies |
Matthew O’Brien |
| Raymond James |
Jayson Bedford |
| RBC Capital Markets |
Shagun Singh Chadha |
| Robert W. Baird & Co. Inc. |
Jeffrey Johnson |
| Stifel Nicolaus & Company, Inc. |
Frederick Wise |
| Truist Securities |
Richard Newitter |
| UBS Equities |
Danielle Antalffy |
| Wells Fargo Securities, LLC |
Lawrence H. Biegelsen |
Stryker Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Stryker Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Stryker Corporation or its management. Stryker Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.